Financials

Total revenue
Net income
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
636
NBIX
Neurocrine Biosciences, Inc. - Common Stock
170.44 USD-2.10%-2.68%+6.60%+17.54%17.14 B USD
788
ELAN
Elanco Animal Health Incorporated Common Stock
25.09 USD-0.24%+1.62%+1.46%+12.03%12.53 B USD
993
ALKS
Alkermes plc - Ordinary Shares
51.02 USD-1.64%-6.37%+15.64%+70.41%8.50 B USD
1120
LNTH
Lantheus Holdings, Inc. - Common Stock
103.80 USD-1.51%+2.31%-0.93%+85.16%6.76 B USD

Frequently asked questions about Dr. Reddy's Laboratories Ltd

What is the Dr. Reddy's Laboratories Ltd stock price today?

The current price of Dr. Reddy's Laboratories Ltd (RDY) is 12.79. Over the past 24 hours, the stock has changed by -1.01%. Follow the RDY chart for real-time price dynamics.

What is the stock ticker of Dr. Reddy's Laboratories Ltd?

Dr. Reddy's Laboratories Ltd trades under the ticker RDY. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Dr. Reddy's Laboratories Ltd stock going up?

RDY has changed by -12.04% over the last week, -4.48% over the last month, and -12.82% over the last year. Review the chart to see whether the current move is part of a broader trend.

Does Dr. Reddy's Laboratories Ltd release financial reports?

Yes. You can track Dr. Reddy's Laboratories Ltd financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

How many employees does Dr. Reddy's Laboratories Ltd have?

As of the latest available data, Dr. Reddy's Laboratories Ltd has 27.53 K employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Dr. Reddy's Laboratories Ltd stock?

You can buy Dr. Reddy's Laboratories Ltd (RDY) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Dr. Reddy's Laboratories Ltd stock?

Investing in Dr. Reddy's Laboratories Ltd requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RDY chart and related analysis on metatrader.com as part of your research.

Dr. Reddy's Laboratories Ltd

Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology. Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe. By 2007, Dr.

News